Lyra Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Lyra Therapeutics, Inc. Website Screenshot

http://www.lyratherapeutics.com

Lyra Therapeutics, Inc. Company Intro

We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.

Industry

Healthcare

Lyra Therapeutics, Inc. Headquaters

480 Arsenal Way
Watertown,02472
United States


Lyra Therapeutics, Inc. Share price

19 Oct 2020 02:02 GMT

$13.09

0.65 (5.23 %)


Lyra Therapeutics, Inc. Market cap

$169.829 M


WMC RANKING

2020

Lyra Therapeutics, Inc. # 479

Biotechnology



Latest Lyra Therapeutics, Inc. News

News 15 Oct 2020

Global Nasal Polyps Treatment Market 2020: Global Industry Applications, Types and Leading Key Players By 2027||Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, Intersect ENT, Inc

Some of the key players profiled in the report are Regeneron Pharmaceuticals, Inc., Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, ...

News 15 Oct 2020

Global Nasal Polyps Treatment Market 2020: Global Industry Applications, Types and Leading Key Players By 2027||Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, Intersect ENT, Inc

Some of the key players profiled in the report are Regeneron Pharmaceuticals, Inc., Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, ...

News 15 Oct 2020

Global Nasal Polyps Treatment Market 2020: Global Industry Applications, Types and Leading Key Players By 2027||Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, Intersect ENT, Inc

Some of the key players profiled in the report are Regeneron Pharmaceuticals, Inc., Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Lyra Therapeutics, Inc. 0 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 11.32 100 20 0 0 96.20
Vertex Pharmaceuticals Incorporated 97.58 100 3.68 33 0 0 100
3SBio Inc. 96.05 0 0 0 0 0 0.06
Incyte Corporation 40.27 8.70 7.11 100 0 0 84.84

Lyra Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Lyra Therapeutics, Inc. $0 $17,407 $-17,601 $169.829M 479
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $27.206B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $56.803B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥20.207B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.821B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Lyra Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Lyra Therapeutics, Inc. Post vs Top 4 Industry Competitors